582 related articles for article (PubMed ID: 8558937)
21. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
[TBL] [Abstract][Full Text] [Related]
22. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
23. A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.
Hedley DW; Xie SX; Minden MD; Choi CH; Chen H; Ling V
Leukemia; 1997 Jan; 11(1):48-53. PubMed ID: 9001418
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
25. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells.
Wada H; Saikawa Y; Niida Y; Nishimura R; Noguchi T; Matsukawa H; Ichihara T; Koizumi S
Exp Hematol; 1999 Jan; 27(1):99-109. PubMed ID: 9923448
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis.
Xu K; Zhuang XX; Shi XW
Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
30. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
Clifford SC; Neal DE; Lunec J
Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
[TBL] [Abstract][Full Text] [Related]
31. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
[TBL] [Abstract][Full Text] [Related]
32. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Illmer T; Schaich M; Oelschlägel U; Nowak R; Renner U; Ziegs B; Subat S; Neubauer A; Ehninger G
Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187
[TBL] [Abstract][Full Text] [Related]
33. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
[TBL] [Abstract][Full Text] [Related]
34. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia.
Ross DD; Karp JE; Chen TT; Doyle LA
Blood; 2000 Jul; 96(1):365-8. PubMed ID: 10891476
[TBL] [Abstract][Full Text] [Related]
35. Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells.
Prenkert M; Uggla B; Tina E; Tidefelt U; Strid H
Anticancer Res; 2009 Oct; 29(10):4071-6. PubMed ID: 19846953
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
37. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
[TBL] [Abstract][Full Text] [Related]
39. Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/Tax) or MRP (HL60/AR).
Kim CH; Gupta S
Int J Oncol; 2000 Jun; 16(6):1137-9. PubMed ID: 10811986
[TBL] [Abstract][Full Text] [Related]
40. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
Gekeler V; Ise W; Sanders KH; Ulrich WR; Beck J
Biochem Biophys Res Commun; 1995 Mar; 208(1):345-52. PubMed ID: 7887949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
